ENO1 and cancer: Studies have confirmed that ENO1 is overexpressed in many tumors and contributes to seven out of the ten hallmarks of cancer: (1) sustaining proliferative signaling, (2) activating invasion and metastasis, (3) inducing angiogenesis, (4) evading growth suppressors, and (5) resisting cell death.